Mozaffarian, D., Agarwal, M., Aggarwal, M., Alexander, L., Apovian, C
The Semaglutide needle is small and thin, and designed for easy self-injecting
speaker/consultation fees from Lundbeck, Janssen, Alkermes, Neumora Therapeutics, Boehringer Ingelheim, Sage, Biogen, Mitsubishi Tanabe, Purdue, Pfizer, Otsuka, Takeda, Neurocrine, Neurawell, Sunovion, Bausch Health, Axsome, Novo Nordisk, Kris, Sanofi, Eisai, Intra-Cellular, NewBridge Pharmaceuticals, Viatris, Abbvie and Atai Life Sciences
However, patients and clinicians have reported anecdotal observations of changes in sexual function during semaglutide treatment, prompting questions about potential connections
perhaps explained by lixisenatides short half-life compared with the long-acting GLP-1RAs being tested in the other CVOTs (Table 1), the short follow-up period of 2 years and the highest percentage of participants on statin therapy (Table 2)
Clinical studies have shown that individuals using semaglutide GLP-1 can achieve substantial weight loss compared to those using a placebo
